The effect of intra-vaginal oxytocin on sexual function in breastfeeding mothers: a randomized triple-blind placebo-controlled trial

Table 2 The mean FSFI total score and its dimensions in study groups

Variable (score range)	Oxytocin n=34	Placebo n= 30	AMD (95% CI)^b	P-value
Variable (score range)	Mean (SD)^a	Mean (SD)^a	AMD (95% CI)^b	P-value
Desire (1.2-6)
Baseline	2.91 (0.96)	3.42 (0.74)
8 weeks	4.38 (1.00)	4.34 (1.13)	0.32 (0.86 to -0.23)	0.253
Arousal (0-6)
Baseline	1.04 (2.98)	3.49 (0.74)
8 weeks	4.41 (1.09)	4.46 (1.04)	0.32 (0.81 to -0.18)	0.208
Lubrication (0-6)
Baseline	3.34 (0.85)	3.60 (0.8)
8 weeks	4.53 (0.87)	4.65 (0.81)	0.06 (0.47 to -0.36)	0.791
Orgasm (0-6)
Baseline	3.21 (1.00)	2.76 (1.1)
8 weeks	4.46 (1.00)	4.53 (1.03)	0.34 (0.77 to 0.08)	0.114
Satisfaction (0.8-6)
Baseline	3.47 (1.26)	4.39 (1.15)
8 weeks	4.85 (1.16)	5.04 (0.90)	0.29 (0.8 to -0.21)	0.252
Pain (0-6)
Baseline	3.56 (1.24)	3.63 (4.46)
8 weeks	4.88 (1.13)	5.12 (0.98)	0.11 (0.41 to -0.64)	0.664
Total FSFI score (2-36)
Baseline	19.48 (4.67)	22.28 (4.15)
8 weeks	27.50 (5.12)	28.14 (4.77)	1.14 (3.57 to -1.28)	0.349

^a Mean (standard deviation)
^b Adjusted mean difference (95% confidence interval)
ANCOVA test adjusted for baseline score was used to compare the mean scores at post-intervention
Higher sexual function scores indicate more favorable conditions

ISSN: 1471-2393